Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Upside Scenarios Outweigh Downside Risks
Go back to Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Upside Scenarios Outweigh Downside Risks| PERNIX THRPTCS HLDG (NASDAQ: PTX) | Delayed: 0.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $4.80 | |||
| Open | $4.01 | 52 Week Low | $0.39 | |||
| Day High | $0.21 | P/E | N/A | |||
| Day Low | $0.21 | EPS | $-0.60 | |||
| Volume | 0 | |||||
